Financial Performance - Total revenue for the nine months ended September 30, 2024, reached 270.2million,up86.0145.2 million in the same period of 2023[11]. - Total revenue for the three months ended September 30, 2024, was 95.5million,asignificantincreasefrom57.7 million in the same period of 2023, representing a growth of 65.5%[11]. - Net earned premium for the three months ended September 30, 2024, was 70.6million,comparedto32.9 million in the prior year, reflecting a growth of 114.5%[11]. - The net loss attributable to Hippo for the three months ended September 30, 2024, was 8.5million,animprovementfromanetlossof53.1 million in the same period of 2023[11]. - Comprehensive loss attributable to Hippo for the nine months ended September 30, 2024, was 81.3million,downfrom230.9 million in the same period of 2023[11]. - The net loss attributable to Hippo for the nine months ended September 30, 2024, was 84.7million,reflectingongoingchallengesinthemarket[79].AssetsandLiabilities−Totalassetsincreasedto1,545.4 million as of September 30, 2024, compared to 1,524.7millionatDecember31,2023[10].−Totalliabilitiesroseto1,215.3 million, up from 1,140.0millionattheendof2023,reflectinganincreaseinlossreservesandunearnedpremiums[10].−Theaccumulateddeficitgrewto(1,319.2) million from (1,234.4)million,highlightingongoingfinancialchallenges[10].−Totalstockholders′equitydecreasedto330.1 million from 384.7million,indicatingadeclineinshareholdervalue[10].−Thecompany′stotalfinancialassetsamountedto585.2 million as of September 30, 2024, compared to 543.9milliononDecember31,2023,reflectingagrowthof7.6191.2 million from 142.1million,indicatingimprovedliquidity[10].−Cashprovidedbyoperatingactivitieswas53.9 million for the quarter, a significant improvement compared to cash used in operating activities of 43.9millioninthesamequarterlastyear[16].−ThenetinvestmentincomeforQ32024was6.2 million, up from 5.7millioninQ32023,indicatingagrowthof8.818.5 million, an increase from 16.9millioninthesameperiodof2023[29].−Thetotalshort−terminvestmentsamountto152.4 million, with a fair value of 152.5millionasofSeptember30,2024[23].ExpensesandCostManagement−Thecompany’stotalexpensesfortheninemonthsendedSeptember30,2024,were344.7 million, a decrease from 368.7millioninthesameperiodof2023[11].−TechnologyanddevelopmentexpensesforQ32024were7.0 million, a decrease of 41.0% from 11.9millioninQ32023[11].−Stock−basedcompensationexpensefortheninemonthsendedSeptember30,2024,was29.3 million, down from 46.8millioninthesameperiodof2023,representingadecreaseofapproximately3793.5 million for the three months ended September 30, 2024, compared to 95.5millionforthesameperiodin2023[77].PremiumsandUnderwriting−DirectwrittenpremiumsforthethreemonthsendedSeptember30,2024,were233.2 million, compared to 225.9millionforthesameperiodin2023,reflectinganincreaseofapproximately3.0234.4 million, a slight increase from 229.5millioninthesameperiodin2023[56].−Thereserveforlossesandlossadjustmentexpenses(LAE),netofreinsurancerecoverables,increasedfrom110.4 million as of September 30, 2023, to 122.5millionasofSeptember30,2024,reflectingariseofapproximately11.950.0 million in March 2023, with $48.2 million remaining available for repurchase as of September 30, 2024[68]. - The total number of common shares increased from 24,148,308 on January 1, 2024, to 25,232,297 by September 30, 2024[13]. - The company has not declared or paid any dividends since inception, with common stock trading under the ticker symbol "HIPO" on the NYSE[59].